Duke Cancer Institute

Sophia Ramirez’s family was told nothing more could be done to cure the toddler’s aggressive leukemia. Then her family brought her to Duke Health, where Sophia received a therapy only available through a clinical trial, followed by a third, successful stem cell transplant. Today, the five-year-old is back home, recovering well, and enjoying life with her family.

https://duke.is/b/g7yf

| | Research | Duke Health

Clinical Trial and Mismatched Cord Blood Transplant Help Toddler Beat Aggressive Leukemia Following two failed bone marrow transplants to treat childhood leukemia, a clinical trial and a mismatched cord blood transplant restores Sophia Ramirez to health.

A federally funded study led by DCI's Jen-Tsan Chi, PhD, finds that the buildup of liquid in the belly helps ovarian cancer cells survive and spread – and that a decades-old cholesterol drug may be able to disrupt that protection.

https://duke.is/9/cq5v

| | Duke University School of Medicine

A common cholesterol drug may weaken ovarian cancer defenses Study reveals ascites is more than a patient symptom, but an active player in helping ovarian cancer spread and grow.

Thanks to everyone who came out to celebrate Clinical Trials Day last week! From our dedicated clinicians and research teams to the patients and families who partner with us, this work is a true collaboration.

| | Duke Health

Reminder to join us this Friday for the annual Hilliard Seigler Duke Melanoma Consortium. This event will explore innovative basic and clinical melanoma research from around the world and specifically highlight the programs at the Duke University Medical Center.

https://duke.is/8/2nnk

| Duke Health

2026 Melanoma Consortium Established in 1988 by Dr. Hilliard Seigler, the annual Hilliard Seigler Duke Melanoma Consortium (The Seig DMC) has been a vital forum for nearly 30 years, bringing together patients, families, and the medical community to learn about advances in melanoma. Formally named to honor Dr. Seigler's life...